[1] UARATANAWONG S, SURAAMORNKUL S, ANGKEAW S, UARATANAWONG R. Prevalence of hyperuricemia in Bangkok population [J]. Clin Rheumatol, 2011, 30(7): 887-893.
[2] COLLABORATION G B D C K D. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 [J]. Lancet, 2020, 395(10225): 709-33.
[3] MIKULS T R, SAAG K G. New insights into gout epidemiology [J]. Curr Opin Rheumatol, 2006, 18(2): 199-203.
[4] LIU R, HAN C, WU D, XIA X, GU J, GUAN H, SHAN Z, TENG W. Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis [J]. Biomed Res Int, 2015, 2015: 762820.
[5] ZHU Y, PANDYA B J, CHOI H K. Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008 [J]. Am J Med, 2012, 125(7): 679-87 e1.
[6] FATHALLAH-SHAYKH S A, CRAMER M T. Uric acid and the kidney [J]. Pediatr Nephrol, 2014, 29(6): 999-1008.
[7] WRIGHT A F, RUDAN I, HASTIE N D, CAMPBELL H. A 'complexity' of urate transporters [J]. Kidney Int, 2010, 78(5): 446-452.
[8] SO A, THORENS B. Uric acid transport and disease [J]. J Clin Invest, 2010, 120(6): 1791-1799.
[9] MERRIMAN T R. An update on the genetic architecture of hyperuricemia and gout [J]. Arthritis Res Ther, 2015, 17(1): 98.
[10] ICHIDA K, MATSUO H, TAKADA T, NAKAYAMA A, MURAKAMI K, SHIMIZU T, YAMANASH Y, KASUGA H, NAKASHINA H, NAKAMURA T, TAKADA Y, KAWAMURA Y, INOUE H, OKADA C, UTSUMI Y, IKEBUCHI Y, ITO K, NAKAMURA, SHINOHARA Y, HOSOYAMADA M, SAKURAL Y, SHINOMIYA N, HOSOYA T, SUZUKI H. Decreased extra-renal urate excretion is a common cause of hyperuricemia [J]. Nat Commun, 2012, 3: 764.
[11] FUJITA K, ICHIDA K. ABCG2 as a therapeutic target candidate for gout [J]. Expert Opin Ther Targets, 2018, 22(2): 123-129.
[12] PáLINKáS M, SZABó E, KULIN A, MóZNER O, RáSONYI R, JUHáSZ P, NAGY K, VáRADY G, V?R?S D, ZáMBó B, SARKADI B, POóR G. Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia [J]. Clin Exp Med, 2022.
[13] WILHELMI DE TOLEDO F, GRUNDLER F, GOUTZOURELAS N, TEKOS F, VASSI E, MESNAGE R, KOURETAS D. Influence of Long-Term Fasting on Blood Redox Status in Humans [J]. Antioxidants (Basel), 2020, 9(6):496.
[14] BELL S, KOLOBOVA I, CRAPPER L, ERNST C. Lesch-Nyhan Syndrome: Models, Theories, and Therapies [J]. Mol Syndromol, 2016, 7(6): 302-311.
[15] WANG Z, CUI T, CI X, et al. The effect of polymorphism of uric acid transporters on uric acid transport [J]. J Nephrol, 2019, 32(2): 177-187.
[16] AZEVEDO V F, KOS I A, VARGAS-SANTOS A B, DA ROCHA CASTELAR PINHEIRO G, DOS SANTOS PAIVA E. Benzbromarone in the treatment of gout [J]. Adv Rheumatol, 2019, 59(1): 37.
[17] 中华内分泌协会.中国高尿酸血症与痛风诊疗指南(2019). [J].中华内分泌代谢杂志，2020，36（1）：1-13
[18] QUARATINO C P, RUCCI C, GIACOMELLO A. Relation between fractional urate excretion and serum triglyceride concentrations [J]. Ann Rheum Dis, 1996, 55(12): 934.
[19] SHICHIRI M, HIRATA Y. [Serum uric acid level and fractional excretion of urate in fluid and electrolyte disturbances] [J]. Rinsho Byori, 1999, 47(5): 417-423.
[20] MAESAKA J K, FISHBANE S. Regulation of renal urate excretion: a critical review [J]. Am J Kidney Dis, 1998, 32(6): 917-933.
[21] MINORS D S, WATERHOUSE J M. Circadian rhythms of urinary excretion: the relationship between the amount excreted and the circadian changes [J]. J Physiol, 1982, 327: 39-51.
[22] MORIWAKI Y, YAMAMOTO T, TAKAHASHI S, YAMAKITA J, TSUTSUMI Z, HADA T. Spot urine uric acid to creatinine ratio used in the estimation of uric acid excretion in primary gout [J]. J Rheumatol, 2001, 28(6): 1306-1310.
[23] 杜静,周灵丽,韩学尧,纪立农.检测晨尿尿酸/肌酐对2型糖尿病患者高尿酸血症分型诊断的意义[J].中国糖尿病杂志,2018,26(08):653-656.
[24] SAKANE N, OKUNO A, NOMAGUCHI K, TANAKA M, ABE F, KAKIUCHI I, KIYOSAWA K, MIYASAKA M, NAKAMURA M. Diagnostic Accuracy of Single Spot Urine for Detecting Renal Uric Acid Underexcretion in Men [J]. J Clin Med Res, 2020, 12(7): 443-447.
[25] WORTMANN R L, FOX I H. Limited value of uric acid to creatinine ratios in estimating uric acid excretion [J]. Ann Intern Med, 1980, 93(6): 822-825.
[26] CHOI ST, SONG JS, KIM SJ, KIM CH, MOON SJ. The Utility of the Random Urine Uric Acid-to-Creatinine Ratio for Patients with Gout Who Need Uricosuric Agents: Retrospective Cross-Sectional Study [J]. J Korean Med Sci, 2020, 35(13): e95.
[27] SIMKIN PA, HOOVER PL, PAXSON CS, WILSON WF. Uric acid excretion: quantitative assessment from spot, midmorning serum and urine samples [J]. Ann Intern Med, 1979, 91(1): 44-47.
[28] PUIG JG, TORRES RJ, DE MIGUEL E, SáNCHEZ A, BAILéN R, BANEGAS JR. Uric acid excretion in healthy subjects: a nomogram to assess the mechanisms underlying purine metabolic disorders [J]. Metabolism, 2012, 61(4): 512-518.
[29] TEO BW, LOH PT, WONG WK, HO PJ, CHOI KP, TOH QC, XU H, SAW S, LAU T, SETHI S, LEE EJ. Spot urine estimations are equivalent to 24-hour urine assessments of urine protein excretion for predicting clinical outcomes [J]. Int J Nephrol, 2015, 2015: 156484.
[30] KANNANGARA DR, RAMASAMY SN, INDRARATNA PL, STOCKER SL, GRAHAM GG, JONES G, PORTEK I, WILLIAMS KM, DAY RO. Fractional clearance of urate: validation of measurement in spot-urine samples in healthy subjects and gouty patients [J]. Arthritis Res Ther, 2012, 14(4): R189.
